Mesenchymal stem cells is named as a drug or biological intervention in 3 clinical trials in our China trial register, 3 of which are recruiting. Lead sponsors include Wuxi Cellular Biopharmaceutical Group Ltd. (1), Sclnow Biotechnology Co., Ltd. (1) and Tasly Pharmaceutical Group Co., Ltd (1). Registered phases: Phase 3, Phase 2 and Phase 1/2. Conditions studied include Knee Osteoarthritis; Osteoarthritis, Knee; Coronary Artery Bypass Grafting (CABG).
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06570291 | Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis (ClinicalTrials.gov ↗) Knee Osteoarthritis |
Phase 3 | Recruiting |
| NCT03383081 | The Safety/Efficacy of hUC Mesenchymal Stem Cells๏ผ19#iSCLifeยฎ-OA๏ผ Therapy for Patients With Osteoarthritis (ClinicalTrials.gov ↗) Osteoarthritis, Knee |
Phase 2 | Recruiting |
| NCT07265349 | A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure (ClinicalTrials.gov ↗) Coronary Artery Bypass Grafting (CABG), Chronic Heart Failure, Chronic Ischemic Cardiomyopathy |
Phase 1/2 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Knee Osteoarthritis | 1 |
| Osteoarthritis, Knee | 1 |
| Coronary Artery Bypass Grafting (CABG) | 1 |
| Chronic Heart Failure | 1 |
| Chronic Ischemic Cardiomyopathy | 1 |
| Lead sponsor | Trials |
|---|---|
| Wuxi Cellular Biopharmaceutical Group Ltd. | 1 |
| Sclnow Biotechnology Co., Ltd. | 1 |
| Tasly Pharmaceutical Group Co., Ltd | 1 |
| Register | Mesenchymal stem cells trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how Mesenchymal stem cells works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Mesenchymal stem cells (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.